"Aromatase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
| Descriptor ID |
D047072
|
| MeSH Number(s) |
D27.505.519.389.870.300 D27.505.696.399.450.327.149 D27.505.696.399.450.855.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aromatase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Aromatase Inhibitors".
This graph shows the total number of publications written about "Aromatase Inhibitors" by people in this website by year, and whether "Aromatase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 7 | 3 | 10 |
| 2018 | 3 | 4 | 7 |
| 2019 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Aromatase Inhibitors" by people in Profiles.
-
COVID-19-induced toxic epidermal necrolysis. Clin Exp Dermatol. 2021 07; 46(5):927-929.
-
A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic. Osteoporos Int. 2021 Jan; 32(1):1-6.
-
Prospective randomized trial comparing efficacy of letrozole step-up protocol with letrozole plus gonadotropins for controlled ovarian stimulation and intrauterine insemination in patients with unexplained infertility. Arch Gynecol Obstet. 2019 12; 300(6):1767-1771.
-
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy. JAMA Netw Open. 2019 09 04; 2(9):e1911080.
-
Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 09 03; 322(9):857-867.
-
Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. J Cancer Surviv. 2019 Aug; 13(4):632-640.
-
Fulvestrant plus anastrozole for metastatic breast cancer. Lancet Oncol. 2019 May; 20(5):e247.
-
Extended adjuvant therapy for early-stage breast cancer: Are there markers for its use? Breast J. 2019 01; 25(1):7-8.
-
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 2018 Oct 08; 363:k3845.
-
Can Acupuncture Keep Women on Their Breast Cancer Drugs? JAMA. 2018 Aug 28; 320(8):744-746.